Neupogen Amgen
Neupogen Amgen is a reference product from Amgen Switzerland AG with at least one biosimilar in Switzerland and is listed on the FOPH Specialities List. The public price ranges from CHF 340.75 to CHF 472.95 depending on the pack; the co-payment is 10 per cent.
Core data
- Authorisation holder
- Amgen Switzerland AG
- ATC code
- L03AA02
- IT group
- 06.07.30 Andere
- Active substances
- Filgrastimum ADNr
- Preparation type
- Reference product
- On the SL since
- 15/03/1994
- Last price change
- 01/12/2025
- Co-payment
- 10%
Prices per pack
The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.
| Dosage form | Pack size | Ex-factory price | Public price | Valid from | Cat. | GTIN |
|---|---|---|---|---|---|---|
| Inj Lös 30 Mio E/ml | Vial 5 Stk | CHF 299.12 | CHF 340.75 | 15/03/1994 | A | 7680510351439 |
| Inj Lös 30 Mio E/0.5ml | Fertspr 5 Stk | CHF 299.12 | CHF 340.75 | 15/03/1996 | A | 7680510351866 |
| Inj Lös 48 Mio E/0.5ml | Fertspr 5 Stk | CHF 421.05 | CHF 472.95 | 15/03/1996 | A | 7680510352085 |
Limitation
This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.
The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.
NEUPOGEN ist indiziert für die Mobilisierung von Vorläuferzellen des peripheren Blutes (PBPC) vor einer Leukapherese, um bei Patienten mit myelosuppressiver Behandlung durch eine Transplantation solcher Zellen die hämatologische Wiederherstellung zu beschleunigen.
Schwere kongenitale Neutropenie (Kostman Syndrom), zyklische Neutropenie, chronische idiopathische Neutropenie (Langzeitanwendung zur Erhöhung der neutrophilen Granulozytenzahl Bereich 1000 bis 3000 Granulozyten pro mcl und Reduktion der Infektionen bei Kindern und Erwachsenen mit klinisch signifikanten Infektionen während der vergangenen 12 Monate und dreimalig dokumentierter schwerster Neutropenie (< 0.5 x 10^9 ANC/l) während 6 Monaten und nach Ausschluss von reaktiv bedingten Neutropenien Vitamin B12 Mangel, Autoimmunkrankheiten).
More preparations in this group
FAQ
Is Neupogen Amgen covered by Swiss health insurance?
Yes, but only under conditions. Neupogen Amgen is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.
What does Neupogen Amgen cost in Switzerland?
The public price is the maximum price set by the FOPH and for Neupogen Amgen ranges from CHF 340.75 to CHF 472.95 per pack. The ex-factory price ranges from CHF 299.12 to CHF 421.05. Pharmacies may not charge more, but may charge less.
Market access
Do you need your product on the Specialities List?
Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.
- Independent directory
- Official FOPH data
- Website in eight languages